Kazia Expands Oncology Platform with First-in-Class SETDB1 Inhibitor
Kazia Therapeutics expands its oncology platform with a first-in-class SETDB1 inhibitor, leveraging an AI-driven epigenetic drug discovery engine for faster and scalable candidate development.
AI Drug Discovery | 15/04/2026 | By News Bureau
Eli Lilly Eyes USD 2 Billion AI Drug Discovery Deal with Insilico Medicine
Eli Lilly is set to enter into a deal worth over USD 2 billion with Hong Kong-based Insilico Medicine to accelerate drug discovery using artificial intelligence, signaling a major push toward AI-driven pharmaceutical innovation.
AI Drug Discovery | 30/03/2026 | By Darshana
Absci Partners with AMD to Propel Future of AI Drug Discovery
AMD will also make a USD 20 million investment in Absci, structured as a private investment in public equity (PIPE), underscoring the growing demand for innovative AI applications in drug discovery.
AI Drug Discovery | 10/01/2025 | By Aishwarya | 275
Syntekabio to Showcase its AI Drug Discovery Tech at Bio-IT World Expo
Syntekabio, a global artificial intelligence (AI) drug discovery pioneer, has announced its participation at the upcoming Bio-IT World Conference & Expo.
AI Drug Discovery | 12/04/2024 | By Aishwarya | 538
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy